View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. SHL
14 January 2019

SHL to Showcase Solutions for High-Volume Drug Delivery at Pharmapack Europe

SHL Group is looking forward to exhibiting at the 2019 Pharmapack, Europe’s dedicated pharmaceutical packaging and drug delivery event from 6-7 February in Paris, France.

At the centre of this year’s exhibition is Molly® 2.25, SHL’s high-volume variation of its classic Molly® auto-injector, which is designed with a preconfigured technology to help pharmaceutical companies minimise initial equipment investments and speed up development timelines.

Boasting an intuitive design that meets a variety of patient handling profiles, Molly® 2.25 supports the trend for injection volumes in the 1-2.25ml range to meet the increasing need for the simple delivery of larger doses. SHL is also looking forward to the market introduction of the first drug product based on the Molly® 2.25 programme.

Another highlight at this year’s event is the range of auto-injectors built with SHL’s Needle Isolation Technology (NIT®). This proprietary technology allows cartridge-based injection devices to be built as easy-to-use auto-injectors with permanently hidden needles.

SHL’s global director of marketing Magnus Fastmarken said: “The NIT® is a true problem solver because cartridges not only open up a world of opportunities for pharma companies, it also offers patients a safe and intuitive experience without sacrificing usability.”

This year, SHL is again pairing up with Innovation Zed to present InsulCheck at Pharmapack’s Innovation Gallery. This year’s display, InsulCheck Connect, is a smart pen injector add-on that displays the time elapsed since the last injection. It can be connected to 3rd party service applications to track insulin injection. InsulCheck Connect is compatible with a variety of existing insulin injection pens on the market and can be customised to support other pen injector projects.

Visitors are invited to explore SHL’s innovative injectable drug delivery solutions at Stand B44 at the Paris Expo Porte de Versailles.

SHL has extensive experience in the parenteral arena. In this article, SHL details its latest offerings in the world of biologics, as well as its...
Despite being founded in an age when medical devices were more about getting the job done than providing optimum patient experience, SHL Group has from...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU